Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-24 @ 10:37 PM
NCT ID:
NCT00830635
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Patients are diagnosed with 1 of the following:
* Diagnosis of prostate cancer (project 1)
* Early-stage disease
* Previously untreated disease or treatment status unknown
* Diagnosis of breast cancer (projects 2-3)
* Early-stage disease
* No ductal carcinoma in situ or lobular carcinoma in situ
* Inflammatory breast cancer allowed (project 2)
* Previously untreated disease, receiving concurrent treatment, previously treated disease, or treatment status unknown
* No more than 30 days since completion of treatment OR no more than 6 months post-treatment (project 3)
PATIENT CHARACTERISTICS:
* Has access to a computer
* Willing to provide mailing address and telephone number
* Must be active information-seekers who have already called the CIS
* Understands English
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00830635
Study Brief:
Protocol Section:
NCT00830635